Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Combination Therapies in the CNS: Engineering the Environment

Combination Therapies in the CNS: Engineering the Environment

Neurosci Lett, 2012 · DOI: 10.1016/j.neulet.2012.02.025 · Published: June 25, 2012

Spinal Cord InjuryNeurologyBiomedical

Simple Explanation

After traumatic brain injury and spinal cord injury, the environment around the injury site becomes inhibitory to axon growth, hindering functional recovery. Combination therapies aim to engineer a more permissive environment in the central nervous system (CNS) to promote regeneration. The inhibitory nature of the CNS lesion means that using multiple therapies together might be more effective than single treatments. This review discusses recent attempts to engineer the CNS environment using combined strategies. These combination therapies involve things like delivering neurotrophins (growth factors), transplanting cells, and using biomaterial scaffolds to help rebuild damaged tissue and encourage axon regeneration.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Level 5, Review

Key Findings

  • 1
    Combining neurotrophic factor delivery with cell transplantation or biomaterial scaffolds may provide synergistic effects to improve functional recovery after spinal cord injury.
  • 2
    Chondroitinase ABC (chABC), an enzyme that degrades inhibitory molecules called CSPGs, can increase axon extension into scaffolds and improve migration and integration of transplanted cells.
  • 3
    Targeting myelin-associated inhibitors (MAIs) with treatments like Nogo-A antibodies or NgR competitive agonist peptides can help regenerating host axons overcome inhibition in white matter and myelin debris.

Research Summary

The review summarizes recent attempts to engineer the CNS extracellular environment after injury using combinatorial strategies involving neurotrophin delivery, cell transplantation, and biomaterial scaffolds. It discusses the advantages and limits of various combination therapies, focusing on treatments that reduce inhibition by chondroitin sulfate proteoglycans, myelin-associated inhibitors, and other barriers to axon regeneration. Based on the current state of the field, the review suggests future directions for research on combination therapies in the CNS, emphasizing the need for consistent and effective treatment methods to maximize recovery.

Practical Implications

Improved Recovery after CNS Injuries

Combination therapies hold promise for enhancing functional recovery following traumatic brain injury (TBI) and spinal cord injury (SCI) by addressing multiple barriers to regeneration.

Enhanced Axon Regeneration

Strategies such as using Chondroitinase ABC (chABC) can promote axon extension and integration of transplanted cells, facilitating better regeneration of neural pathways.

Development of Targeted Treatments

Targeting specific inhibitory molecules like myelin-associated inhibitors (MAIs) can improve axon regeneration in white matter, leading to more effective therapies.

Study Limitations

  • 1
    Variability in combination therapies makes it difficult to determine optimal components.
  • 2
    Inconsistencies in functional outcomes reported with cAMP and anti-MAI therapies.
  • 3
    Lack of suitable sources for Schwann cells limits their use in acute treatments.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury